Assigning single clinical features to their disease-locus in large deletions: the example of chromosome 1q23-25 deletion syndrome

Abstract

Aim: Assigning a disease-locus within the shortest regions of overlap (SRO) shared by deleted/duplicated subjects presenting this disease is a robust mapping approach, although the presence of different malformation traits and their attendance only in a part of the affected subjects can hinder the interpretation. To overcome the problem of incomplete penetrance, we developed an algorithm that we applied to the deletion region 1q23.3-q25, which contains three SROs, each contributing to the abnormal phenotype without clearly distinguishing between the different malformations. We describe six new subjects, including a healthy father and his daughter, with 1q23.3-q25 deletion of different sizes. The aim of this study was to correlate specific abnormal traits to the haploinsufficiency of specific gene/putative regulatory elements.

Methods: Merging cases with those in the literature, we considered four traits, namely intellectual disability (ID), microcephaly, short-hands/feet, and brachydactyly, and conceived a mathematical model to predict with what probability the haploinsufficiency of a specific portion of the deletion region is associated with one of the four malformations.

Results: The haploinsufficiency of PBX1 is strongly associated with ID. DNM3 and LHX4 are confirmed as responsible for growth retardation, whereas ATPIB1 was identified as a new candidate gene for microcephaly, short-hands/feet, and brachydactyly.

Conclusion: Although our model is hampered by long-term position effects of regulatory elements, synergistic cooperation of several genes, and incomplete clinical assessment, it can be useful for contiguous gene syndromes showing a complex pattern of clinical characteristics. Obviously, functional approaches are needed to warrant its reliability.

Keywords

PBX1 / genotype-phenotype / haploinsufficiency / incomplete penetrance / ATP1B1 / microcephaly / contiguous gene syndrome

References

[1] ChatronN,AndrieuxJ,BouteO.Refinement of genotype-phenotype correlation in 18 patients carrying a 1q24q25 deletion..Am J Med Genet A2015;167:1008-17

[2] LefroyH,JavaidMK,ShearsDJ.1q24 deletion syndrome. Two cases and new insights into genotype-phenotype correlations..Am J Med Genet A2018;176:2004-8

[3] FilgesI,RöthlisbergerB,GlanzmannR.Panhypopituitarism presenting as life-threatening heart failure caused by an inherited microdeletion in 1q25 including LHX4..Pediatrics2012;129:e529-34

[4] BurkardtDD,HelgesonML,BanksV.Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25..Am J Med Genet A2011;155:1336-51 PMCID:PMC3109510

[5] Della MonicaM,FaravelliF,LuquettiDV.A case of autism with an interstitial 1q deletion (1q23.3-24.2) and a de novo translocation of chromosomes 1q and 5q..Am J Med Genet A2007;143:2733-7

[6] AshrafT,FairhurstJ,WilsonLC.Two further patients with the 1q24 deletion syndrome expand the phenotype: A possible role for the miR199-214 cluster in the skeletal features of the condition..Am J Med Genet A2015;167:3153-60

[7] LamF.Nine year old boy with chromosome 1q23.3-q25.1 deletion..Am J Med Genet A2016;170:3013-7

[8] HoshinaT,ShimonoT,OkuyamaT.Narrowing down the region responsible for 1q23.3q24.1 microdeletion by identifying the smallest deletion..Hum Genome Var2019;6:47 PMCID:PMC6804575

[9] SunM,LiQ,LiY.Prenatal findings and molecular cytogenetic analyses of a de novo interstitial deletion of 1q23.3 encompassing PBX1 gene..Taiwan J Obstet Gynecol2019;58:292-5

[10] ArcaleniE.Secular trend and regional differences in the stature of Italians..J Anthropol Sci2012;90:233-7

[11] Van der AuweraGA,HartlC,Del AngelG.From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline..Curr Protoc Bioinformatics2013;43:11.10.1-33 PMCID:PMC4243306

[12] YangH.Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR..Nat Protoc2015;10:1556-66 PMCID:PMC4718734

[13] McKennaA,BanksE,CibulskisK.The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data..Genome Res2010;20:1297-303 PMCID:PMC2928508

[14] ChaseMB,PurtellDC,ShenRF.Mapping of the human thromboxane synthase gene (TBXAS1) to chromosome 7q34-q35 by two-color fluorescence in situ hybridization..Genomics1993;16:771-3

[15] SlavotinekA,LosaM,MonaghanKG.De novo, deleterious sequence variants that alter the transcriptional activity of the homeoprotein PBX1 are associated with intellectual disability and pleiotropic developmental defects..Hum Mol Genet2017;26:4849-60 PMCID:PMC6455034

[16] Le TannoP,BidartM,HarbuzR.PBX1 haploinsufficiency leads to syndromic congenital anomalies of the kidney and urinary tract (CAKUT) in humans..J Med Genet2017;54:502-10

[17] GenomicRelationships.Pleiotropic mechanisms across eight psychiatric disorders..Cell2019;179:1469-82 PMCID:PMC7077032

[18] ClausenMV,PoulsenH.The structure and function of the Na,K-ATPase isoforms in health and disease..Front Physiol2017;8:371 PMCID:PMC5459889

[19] LanciottiA,MolinariP,De NuccioC.Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations..Hum Mol Genet2012;21:2166-80

[20] KrakowD,CamachoN,DeixlerH.Mutations in the gene encoding the calciumpermeable ion channel TRPV4 produce spondylometaphyseal dysplasia, kozlowski type and metatropic dysplasia..American Journal of Human Genetics2019;84:307-15 PMCID:PMC2667978

[21] NiliusB.The puzzle of TRPV4 channelopathies..EMBO Reports2013;14:152-63 PMCID:PMC3566843

[22] ThibodeauML,TownsendKN,HendsonG.Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy..Am J Med Genet A2017;173:3087-92

[23] WatanabeT,AmanoT,KawamuraN.Dnm3os, a non-coding RNA, is required for normal growth and skeletal development in mice..Dev Dyn2008;237:3738-48

[24] LinEA,BaiXH,LiuCJ.miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1..J Biol Chem2009;284:11326-35 PMCID:PMC2670138

[25] ShiK,ZhaoY,LiJ.MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix..Bone2013;55:487-94

[26] XatzipsaltiM,StamoyannouL,Kanaka-GantenbeinC.Congenital hypopituitarism: various Genes, various phenotypes..Horm Metab Res2019;51:81-90

[27] NishimuraA,ShimodaH,TadakiH.De novo deletion of 1q24.3-q31.2 in a patient with severe growth retardation..Am J Med Genet A2010;152:1322-5

[28] BoonsawatP,SteindlK,GogollL.Elucidation of the phenotypic spectrum and genetic landscape in primary and secondary microcephaly..Genet Med2019;21:2043-58 PMCID:PMC6752480

[29] SharmaD,FarahbakhshN.Intrauterine growth restriction-part 1..J Matern Fetal Neonatal Med2016;29:3977-87

[30] TsujitaY,TanabeT.Role of a genetic variation in the promoter of human thromboxane synthase gene in myocardial infarction..Atherosclerosis2000;153:261-2

[31] YiX,WangC,MaC.Variants in COX-2, PTGIS, and TBXAS1 are associated with carotid artery or intracranial arterial stenosis and neurologic deterioration in ischemic stroke patients..J Stroke Cerebrovasc Dis2017;26:1128-35

[32] ShantaO.Human genome structural variation consortium (HGSVC), Sebat J. The effects of common structural variants on 3D chromatin structure..BMC Genomics2020;21:95 PMCID:PMC6990566